Benjamin B. Kasten

university of alabama

H指数:15

被引数:676

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Harnessing Id1 as a biomarker in a plasmid reporter system for cervical cancer

利用Id1作为宫颈癌细胞系中质粒报告系统的生物标志物

Scientific Reports

IF3.9

2026-04-190

OAAI

Challenges and Opportunities in High-Grade Glioma Management and Imaging-Based Response Monitoring During Novel Immunotherapies

高级别胶质瘤管理及新型免疫疗法期间基于成像的疗效监测的挑战与机遇

Cancers 2025, Vol. 17, Page 3176

IF4.4

2025-09-300

OAAI

Background Tissue with Native Target Expression Can Determine Presence of Nodal Metastasis in Head and Neck Squamous Cell Carcinoma Patients Infused with Targeted Fluorescent Tracers

MOLECULAR IMAGING AND BIOLOGY

IF2.5

2025-03-010

OAAI

Comparison of 5-aminolevulinic acid and MMP-14 targeted peptide probes in preclinical models of GBM

5-氨基乙酰丙酸与MMP-14靶向肽探针在GBM临床前模型中的比较

THERANOSTICS

IF13.3

2025-02-240

Novel plasmid-based screening method for cervical cancer

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Positron emission tomography imaging with 89Zr-labeled anti-CD8 cys-diabody reveals CD8+ cell infiltration during oncolytic virus therapy in a glioma murine model (vol 11, 15384, 2021)

SCIENTIFIC REPORTS

IF3.9

2021-10-080

OAAI

Positron emission tomography imaging with 89Zr-labeled anti-CD8 cys-diabody reveals CD8+ cell infiltration during oncolytic virus therapy in a glioma murine model

SCIENTIFIC REPORTS

IF3.9

2021-07-2822

OAAI

B7-H3-targeted Radioimmunotherapy of Human Cancer

人类癌症的B7-H3-targeted放射免疫治疗

CURRENT MEDICINAL CHEMISTRY

IF3.5

2020-07-075

Targeting MMP-14 for dual PET and fluorescence imaging of glioma in preclinical models

临床前模型中胶质瘤双重PET和荧光成像的靶向MMP-14

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2019-11-2635

OAAI

Fluorescence Imaging of Nerves During Surgery

ANNALS OF SURGERY

IF6.4

2019-07-0157

PREAI

Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-Oncology

评估神经肿瘤学免疫治疗反应的当前和未来成像方法

THERANOSTICS

IF13.3

2019-01-0128

OAAI

212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models (vol 58, pg 67, 2018 )

NUCLEAR MEDICINE AND BIOLOGY

IF3

2018-06-011

OAAI

212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models

NUCLEAR MEDICINE AND BIOLOGY

IF3

2018-03-0151

OAAI

B7-H3-targeted 212Pb radioimmunotherapy of ovarian cancer in preclinical models

NUCLEAR MEDICINE AND BIOLOGY

IF3

2017-04-0171

OAAI

Imaging, biodistribution, and toxicology evaluation of 212Pb-TCMC-trastuzumab in nonhuman primates

212pb-tcmc-曲妥珠单抗在非人类灵长类动物中的成像，生物分布和毒理学评估

NUCLEAR MEDICINE AND BIOLOGY

IF3

2016-07-0120

PREAI

Isothiocyanate-Functionalized Bifunctional Chelates and fac-[MI(CO)3]+ (M = Re, 99mTc) Complexes for Targeting uPAR in Prostate Cancer

BIOCONJUGATE CHEMISTRY

IF3.9

2015-12-309

OAAI

Clickable, Hydrophilic Ligand for fac-[MI(CO)3]+ (M = Re/99mTc) Applied in an S-Functionalized α-MSH Peptide

BIOCONJUGATE CHEMISTRY

IF3.9

2014-02-2538

OAAI

Cu-Free 1,3-Dipolar Cycloaddition Click Reactions To Form Isoxazole Linkers in Chelating Ligands for fac-[MI(CO)3]+ Centers (M = Re, 99mTc)

INORGANIC CHEMISTRY

IF4.7

2014-01-314

Rhenium and technetium bi-and tricarbonyl complexes in a new strategy for biomolecule incorporation using click chemistry

DALTON TRANSACTIONS

IF3.3

2014-01-0120

OAAI

Re and 99mTc complexes of BodP3 - multi-modality imaging probes

CHEMICAL COMMUNICATIONS

IF4.2

2014-01-0120

OAAI

Benjamin B. Kasten

个人简介

教育背景

工作经历

荣誉奖项

研究方向